M. A. Carroll

603 total citations
11 papers, 482 citations indexed

About

M. A. Carroll is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, M. A. Carroll has authored 11 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Otorhinolaryngology. Recurrent topics in M. A. Carroll's work include Head and Neck Cancer Studies (5 papers), Head and Neck Surgical Oncology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). M. A. Carroll is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Head and Neck Surgical Oncology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). M. A. Carroll collaborates with scholars based in United States. M. A. Carroll's co-authors include David J. Adelstein, Lisa Rybicki, Ramon M. Esclamado, Marshall Strome, Benjamin G. Wood, Pierre Lavertu, Jerrold P. Saxton, Robert R. Lorenz, Thomas W. Rice and Ann Tan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Lung Cancer.

In The Last Decade

M. A. Carroll

11 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. A. Carroll United States	7	389	334	184	170	34	11	482
Marjorie A. Van Kirk United States	8	239 0.6×	201 0.6×	109 0.6×	221 1.3×	25 0.7×	10	396
B.S. Glisson United States	7	258 0.7×	173 0.5×	169 0.9×	166 1.0×	14 0.4×	10	357
F. Rosen United States	6	314 0.8×	219 0.7×	152 0.8×	118 0.7×	30 0.9×	10	399
Ch. Popella Germany	3	454 1.2×	327 1.0×	181 1.0×	210 1.2×	19 0.6×	4	504
Luciana Lastrucci Italy	9	250 0.6×	131 0.4×	111 0.6×	179 1.1×	50 1.5×	12	344
Charissa Goh Singapore	5	273 0.7×	196 0.6×	124 0.7×	102 0.6×	10 0.3×	14	325
Christian Sire France	11	224 0.6×	108 0.3×	191 1.0×	124 0.7×	23 0.7×	21	329
R. Cavagnini Italy	3	163 0.4×	77 0.2×	74 0.4×	125 0.7×	21 0.6×	5	212
Judith Wacha United States	5	354 0.9×	190 0.6×	74 0.4×	184 1.1×	45 1.3×	7	398
Chun‐Ta Liao Taiwan	6	250 0.6×	190 0.6×	129 0.7×	64 0.4×	47 1.4×	8	311

Countries citing papers authored by M. A. Carroll

Since Specialization

Citations

This map shows the geographic impact of M. A. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Carroll more than expected).

Fields of papers citing papers by M. A. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Carroll. The network helps show where M. A. Carroll may publish in the future.

Co-authorship network of co-authors of M. A. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Carroll. A scholar is included among the top collaborators of M. A. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Carroll. M. A. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Conti, Peter S., et al.. (2012). Abstract P2-05-10: 64Cu-DOTA-trastuzumab positron emission tomography imaging of HER2 in women with advanced breast cancer. Cancer Research. 72(24_Supplement). P2–5. 2 indexed citations

Rodriguez, Cristina P., David J. Adelstein, Lisa Rybicki, et al.. (2008). Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy. Head & Neck. 30(12). 1535–1542. 16 indexed citations

Adelstein, David J., Thomas W. Rice, Lisa Rybicki, et al.. (2007). A Phase II Trial of Accelerated Multimodality Therapy for Locoregionally Advanced Cancer of the Esophagus and Gastroesophageal Junction. American Journal of Clinical Oncology. 30(2). 172–180. 16 indexed citations

Tan, Ann, David J. Adelstein, Lisa Rybicki, et al.. (2007). Ability of Positron Emission Tomography to Detect Residual Neck Node Disease in Patients With Head and Neck Squamous Cell Carcinoma After Definitive Chemoradiotherapy. Archives of Otolaryngology - Head and Neck Surgery. 133(5). 435–435. 56 indexed citations

Adelstein, David J., Jerrold P. Saxton, Lisa Rybicki, et al.. (2006). Multiagent Concurrent Chemoradiotherapy for Locoregionally Advanced Squamous Cell Head and Neck Cancer: Mature Results From a Single Institution. Journal of Clinical Oncology. 24(7). 1064–1071. 121 indexed citations

Adelstein, David J., Lisa Rybicki, M. A. Carroll, Thomas W. Rice, & Tarek Mekhail. (2005). Phase II trial of gefitinib for recurrent or metastatic esophageal or gastroesophageal junction (GEJ) cancer. Journal of Clinical Oncology. 23(16_suppl). 4054–4054. 29 indexed citations

Adelstein, David J., Lisa Rybicki, Jerrold P. Saxton, et al.. (2004). Is the second primary malignancy an important competing cause of death in patients (pts) with squamous cell head and neck cancer (SCHNC)?. Journal of Clinical Oncology. 22(14_suppl). 5516–5516. 1 indexed citations

Adelstein, David J., Thomas W. Rice, L. A. Rybicki, et al.. (2004). Long-term follow-up after chemoradiotherapy (CRT) and surgery in patients (pts) with stage III non-small cell lung cancer (NSCLC): Is bulky mediastinal nodal disease of prognostic importance. Journal of Clinical Oncology. 22(14_suppl). 7168–7168. 1 indexed citations

Adelstein, David J., Lisa Rybicki, Pierre Lavertu, et al.. (2003). Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?. Head & Neck. 25(10). 791–798. 134 indexed citations

10.

Adelstein, David J., Thomas W. Rice, Lisa Rybicki, et al.. (2002). Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer. Lung Cancer. 36(2). 167–174. 6 indexed citations

11.

Adelstein, David J., Jerrold P. Saxton, Pierre Lavertu, et al.. (2002). Maximizing Local Control and Organ Preservation in Stage IV Squamous Cell Head and Neck Cancer With Hyperfractionated Radiation and Concurrent Chemotherapy. Journal of Clinical Oncology. 20(5). 1405–1410. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact